Log in
Enquire now
‌

US Patent 11359025 Anti-IL1-RAP antibodies

Patent 11359025 was granted and assigned to Cantargia on June, 2022 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors
Is a
Patent
Patent
0
Current Assignee
‌
Cantargia
0
Date Filed
October 16, 2017
0
Date of Patent
June 14, 2022
0
Patent Applicant
‌
Cantargia
0
Patent Application Number
16342176
0
Patent Citations
‌
US Patent 10005841 Method of treating a solid tumor with IL1RAP antibodies
‌
US Patent 10100119 Anti-human interleukin-1 receptor accessory protein antibody and its use for treating cancer
‌
US Patent 10287357 Methods of treating cancer using anti human interleukin-1 receptor accessory protein (IL1 RAP) antibodies
‌
US Patent 10562971 Method of detection of IL1RAP on cells expressing the protein
‌
US Patent 10005842 Method of treatment for leukemia using an anti-IL1RAP antibody
Patent Inventor Names
Jagath R. Junutula
0
Leonard G. Presta
0
Ying Ping Jiang
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
11359025
0
Patent Primary Examiner
‌
Brian Gangle
0

Find more entities like US Patent 11359025 Anti-IL1-RAP antibodies

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.